Promising therapeutic targets for the treatment of urine storage dysfunction : what’s the status?
Introduction: Opinions differ on what drugs have both a rationale and a development potential for the treatment of bladder storage dysfunction. Areas covered: In the present review, the focus is given to small molecule blockers of TRP channels (TRPV1, TRPV4, TRPA1, and TRPM8), P2 × 3receptor antagonists, drugs against oxidative stress, antifibrosis agents, cyclic nucleotide–dependent pathways, and
